Expansion of stemlike HIV-specific CD8 + T cells and limited viral epitope diversity characterize durable posttreatment control of HIV
Authors:
- Charles R. CrainCCCharles R. Crain
- Aljawharah AlrubayyiAljawharah Alrubayyi
- Itai MuzhingiIMItai Muzhingi
- Anna TraunbauerATAnna Traunbauer
- Esther JeonEJEsther Jeon
- Rinki DeoRDRinki Deo
- Efthimios A. DeligiannidisEDEfthimios A. Deligiannidis
- Prerana ShresthaPSPrerana Shrestha
- Behzad EtemadBEBehzad Etemad
- Hannah MacLeodHMHannah MacLeod
- Gregory M. LairdGregory M. Laird
- Manish C. ChoudharyManish C. Choudhary
Top Cited Papers
- 22 April 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (846) , eaed0042
Abstract
Individuals who durably control HIV after cessation of antiretroviral therapy (ART) are of great interest for HIV cure efforts, but the correlates of posttreatment control remain incompletely understood. Here, we show across a diverse cohort of posttreatment controllers (PTCs), posttreatment noncontrollers (NCs), and spontaneous elite controllers (ECs) that robust expansion of HIV-specific CD8 + T cells and reduced viral reservoir diversity were strongly associated with durable (>1 year) viral suppression after ART cessation. In addition, HIV-specific CD8 + T cells in PTCs exhibited a stemlike memory phenotype, characterized by high TCF-1 (T cell factor 1) and low TOX (thymocyte selection–associated HMG box) expression, and readily differentiated into cytolytic effectors. Mapping of CD8 + T cell responses from PTCs revealed broad targeting of epitopes in a conserved autologous reservoir, whereas preferential targeting of epitopes derived from mutationally constrained regions was primarily a feature of CD8 + T cells from ECs. Univariable and additive analyses revealed a link between HIV-specific CD8 + T cell expansion, a stemlike phenotype, and conservation of human leukocyte antigen class I–restricted viral epitopes with posttreatment control. Together, these findings identify features of HIV-specific CD8 + T cells and the viral reservoir that are associated with sustained HIV control after ART cessation, informing future immunotherapeutic strategies toward achieving an HIV cure.Keywords
Funding Information
- National Institutes of Health (UM1AI154560)
- National Institutes of Health (DP2AI154421)
- National Institutes of Health (R24AI143502)
- National Institutes of Health (K23AI157875)
- Burroughs Wellcome Career Award for Medical Scientists (N/A)
This publication has 47 references indexed in Scilit:
- Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cellsEBioMedicine, 2022
- The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responsesCell Reports, 2022
- Analytical Treatment Interruption in HIV Trials: Statistical and Study Design ConsiderationsCurrent HIV/AIDS Reports, 2021
- HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIVCell Reports, 2021
- Dysfunctional HIV-Specific CD8+ T Cell Proliferation Is Associated with Increased Caspase-8 Activity and Mediated by NecroptosisImmunity, 2014
- Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen DesignImmunity, 2013
- Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV SeroconversionArchives of internal medicine (1960), 2012
- HIV and Inflammation: Mechanisms and ConsequencesCurrent HIV/AIDS Reports, 2012
- Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1Immunity, 2010
- Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune ControlImmunity, 2008